Inogen Donates Medical Device to Holocaust Survivor on International Holocaust Remembrance Day 2015
GOLETA, Calif., Jan. 27, 2015 (GLOBE NEWSWIRE) -- Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that in honor of International Holocaust Remembrance Day 2015, the Company is donating an Inogen One G3 portable oxygen concentrator to Holocaust Survivor, Ben Fainer. Inogen was founded on the belief that oxygen therapy users deserve independence and, as a result, have developed innovative portable oxygen concentrator technology that eliminates a patient's concern of running out of oxygen in a tank.
Ben Fainer endured six different Nazi concentration camps between ages 9 and 15 before he was liberated. As a Jew in Bedzin, Poland in 1939, Mr. Fainer was separated from his mother and siblings, whom he never saw again. He endured "death marches" of considerable distance each time he was moved to another camp. Mr. Fainer was selected to clean the SS quarters and was able to survive by finding leftover food which he would often hide to bring back to others in the barracks. Other times he would stave off hunger by smoking chestnut leaves, which most likely was a contributing factor to his lung disease realized many years later. Mr. Fainer has been held prisoner by oxygen tanks that severely restrict his independence. Now an author and traveling speaker, Mr, Fainer has had his quality of life impaired by traditional forms of oxygen therapy.
Byron Myers, Inogen Founder and VP Marketing stated, "We are proud to honor Mr. Fainer today and hope that the Inogen One G3 helps to restore freedom so he can live life how he sees fit, surrounded by family and sharing his courageous testimony with others around the country."
Mr. Fainer added, "I know something about freedom – about losing it and how it feels to regain it. I can't thank Inogen enough for the gift of freedom they are providing to me in the Inogen One G3."
Inogen has used, and intends to continue to use, its Investor Relations website, www.inogen.com/investor, as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit www.inogen.com/investor.
Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
CONTACT: Investor Relations Contact: email@example.com 805-562-0500 ext 7 Media Contact: Byron Myers 805-562-0503
Released January 27, 2015